Efficacy of etravirine combined with darunavir or other ritonavir‐boosted protease inhibitors in HIV‐1‐infected patients: an observational study using pooled European cohort data

Objectives This observational study in antiretroviral treatment‐experienced, HIV‐1‐infected adults explored the efficacy of etravirine plus darunavir/ritonavir (DRV group; n = 999) vs. etravirine plus an alternative boosted protease inhibitor (other PI group; n = 116) using pooled European cohort da...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	HIV medicine 2015-05, Vol.16 (5), p.297-306
Hauptverfasser:	Vingerhoets, J, Calvez, V, Flandre, P, Marcelin, A‐G, Ceccherini‐Silberstein, F, Perno, C‐F, Mercedes Santoro, M, Bateson, R, Nelson, M, Cozzi‐Lepri, A, Grarup, J, Lundgren, J, Incardona, F, Kaiser, R, Sonnerborg, A, Clotet, B, Paredes, R, Günthard, HF, Ledergerber, B, Hoogstoel, A, Nijs, S, Tambuyzer, L, Lavreys, L, Opsomer, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral agents Antiviral agents CD4 Lymphocyte Count Darunavir darunavir/ritonavir Drug Therapy, Combination Effectiveness efficacy etravirine Female France - epidemiology Heterogeneity HIV HIV Infections - drug therapy HIV Infections - epidemiology HIV Protease Inhibitors - administration & dosage HIV‐1 Human immunodeficiency virus Human immunodeficiency virus 1 Humans Italy - epidemiology Male Meta-Analysis as Topic Middle Aged Observational studies Odds Ratio Protease protease inhibitor Protease inhibitors Proteinase inhibitors Pyridazines - administration & dosage Ritonavir Ritonavir - administration & dosage Spain - epidemiology Sulfonamides - administration & dosage Switzerland - epidemiology United Kingdom - epidemiology Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!